(fra kommisjonsforordningen)

(1) Commission Directive 2004/30/EC included pyraclostrobin as an active substance in Annex I to Council Directive 91/414/EEC. 

(2) Active substances included in Annex I to Directive 91/414/EEC are deemed to have been approved under Regulation (EC) No 1107/2009 and are listed in Part A of the Annex to Commission Implementing Regulation (EU) No 540/2011. 

(3) The approval of the active substance pyraclostrobin, as set out in Part A of the Annex to Implementing Regulation (EU) No 540/2011, expires on 15 December 2026. 

(4) An application for the renewal of the approval of the active substance pyraclostrobin was submitted to Germany, the rapporteur Member State, and Hungary, the corapporteur Member State, in accordance with Article 1 of Commission Implementing Regulation (EU) No 844/2012 and within the time period provided for in that Article. 

(5) The applicant submitted the supplementary dossiers required to the rapporteur Member State, the co-rapporteur Member State, the Commission and the European Food Safety Authority (‘the Authority’) in accordance with Article 6 of Implementing Regulation (EU) No 844/2012. The application was found to be admissible by the rapporteur Member State. 

(6) The rapporteur Member State prepared a draft renewal assessment report in consultation with the co-rapporteur Member State and submitted it to the Authority and the Commission on 19 February 2018. In its draft renewal assessment report, the rapporteur Member State proposed to renew the approval of pyraclostrobin. 

(7) The Authority made the supplementary summary dossier available to the public. The Authority also circulated the draft renewal assessment report to the applicant and to the Member States for comments and launched a public consultation on it. The Authority forwarded the comments received to the Commission. 

(8) On 29 November 2019, the Authority requested additional information on the endocrine disrupting properties of pyraclostrobin pursuant to Article 13(3a) of Implementing Regulation (EU) No 844/2012. The applicant submitted the information required to determine whether pyraclostrobin fulfils the criteria for identifying the endocrine disrupting properties of a substance set out in point 3.6.5 and point 3.8.2 of Annex II to Regulation (EC) No 1107/2009, as introduced by Commission Regulation (EU) 2018/6056 . 

(9) On 8 June 2022, the rapporteur Member State made the updated draft renewal assessment report available to the Authority, the Member States and the Commission. In its updated draft renewal assessment report, the rapporteur Member State evaluated the additional information on endocrine disrupting properties of pyraclostrobin and, in light of that information, maintained its proposition to renew the approval of pyraclostrobin. 

(10) On 29 January 2025, the Authority communicated to the Commission its conclusion indicating that, taking into account the approval criteria laid down in Annex II to Regulation (EC) No 1107/2009, plant protection products containing pyraclostrobin can be expected to meet the approval criteria provided for in Article 4 of Regulation (EC) No 1107/2009. The Authority identified no critical area of concern. 

(11) The Commission presented the draft renewal report and a draft of this Regulation to the Standing Committee on Plants, Animals, Food and Feed on 5 May 2026. 

(12) The Commission invited the applicant to submit its comments on the conclusion of the Authority and, in accordance with Article 14(1), third subparagraph, of Implementing Regulation (EU) No 844/2012, on the renewal report. The applicant submitted its comments, which have been carefully examined and taken into consideration. 

(13) It has been established with respect to one or more representative uses of at least one plant protection product containing the active substance pyraclostrobin that the approval criteria provided for in Article 4 of Regulation (EC) No 1107/2009 are satisfied. 

(14) Although the risk assessment for the renewal of the approval of the active substance pyraclostrobin is based on a limited number of representative uses, this does not restrict the uses for which plant protection products containing pyraclostrobin may be authorised. It is therefore appropriate not to maintain the restriction to use as a fungicide and plant growth regulator. 

(15) It is therefore appropriate to renew the approval of pyraclostrobin. In accordance with Article 14(1) of Regulation (EC) No 1107/2009 in conjunction with Article 6 thereof, it is, however, necessary to provide for certain conditions. 

(16) It is, in particular, appropriate to set maximum limits for dimethyl sulfate and toluene, which are toxicologically relevant impurities that might be present in the technical material as manufactured, to ensure that the active substance pyraclostrobin used in plant protection products does not lead to any harmful effects on human health. 

(17) Taking into account the outcome of the risk assessment it is necessary to require that Member States, when authorising plant protection products containing pyraclostrobin, pay particular attention to the assessment of co-formulants used in pyraclostrobincontaining plant protection products, the protection of aquatic organisms and the consumer risk assessment, including by imposing mitigation measures, where applicable. 

(18) Moreover, it is appropriate to require confirmatory information to increase the confidence in the conclusion that there is no concern from possible exposure of consumers to metabolite 500M07 and to confirm the residue definition for risk assessment for commodities of plant or animal origin. 

(19) Finally, given that new scientific and technical knowledge on the assessment of the potential effects of water treatment processes on residues of active substances or their metabolites in water, abstracted for the production of drinking water, has been developed during the evaluation process, which was not available at the time of the submission of the supplementary dossier for pyraclostrobin, notably a Guidance Document8 , the applicant should provide confirmatory information on the effects of water treatment processes on residues of pyraclostrobin or its metabolites potentially present in surface water, when surface water is abstracted for drinking water. 

(20) Implementing Regulation (EU) No 540/2011 should therefore be amended accordingly. 

(21) Commission Implementing Regulation C(2026) 7603 extended the expiry date of pyraclostrobin to 15 December 2026 in order to allow the renewal process to be completed before the expiry of the approval period of that active substance. However, given that a decision on renewal has been taken ahead of that extended expiry date, this Regulation should apply earlier than that date. 

(22) The measures provided for in this Regulation are in accordance with the opinion of the Standing Committee on Plants, Animals, Food and Feed,